Nucleolar disruption impairs Kaposi’s sarcoma-associated herpesvirus ORF57-mediated nuclear export of intronless viral mRNAs  by Boyne, James R. & Whitehouse, Adrian
FEBS Letters 583 (2009) 3549–3556journal homepage: www.FEBSLetters .orgNucleolar disruption impairs Kaposi’s sarcoma-associated herpesvirus
ORF57-mediated nuclear export of intronless viral mRNAs
James R. Boyne a,c, Adrian Whitehouse a,b,*
a Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK
bAstbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK
cDivision of Biomedical Sciences, School of Life Sciences, University of Bradford, Bradford, BD7 1DP, UK
a r t i c l e i n f o a b s t r a c tArticle history:
Received 20 July 2009
Revised 25 September 2009
Accepted 12 October 2009
Available online 20 October 2009
Edited by Hans-Dieter Klenk
Keywords:
Nucleolus
mRNA
Nuclear export
Herpesvirus0014-5793/$36.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.10.040
* Corresponding author. Address: Institute of Mo
Faculty of Biological Sciences, University of Leeds, L
(0)113 3433167.
E-mail address: a.whitehouse@leeds.ac.uk (A. WhiKaposi’s sarcoma-associated herpesvirus (KSHV) ORF57 plays a pivotal role in mediating the nuclear
export of KSHV intronless transcripts. We demonstrate that ORF57 localises and dynamically traff-
icks through the nucleolus. To assess if nucleolar shuttling of ORF57 is important for the export of
intronless viral mRNA, the ability of ORF57 to export mRNA was assessed in cells where the nucleo-
lus was disrupted using Actinomycin D or DRB. We show that rapid disorganisation of the nucleolus
was accompanied by a reduction in intronless virus mRNA export, suggesting that an intact nucleo-
lus is essential for efﬁcient KSHV ORF57-mediated intronless mRNA export.
Structured summary:
MINT-7291377: Aly (uniprotkb:Q86V81) physically interacts (MI:0915) with ORF57 (uniprotkb:Q2HR75)
by pull down (MI:0096)
MINT-7291330, MINT-7291320: Nucleolin (uniprotkb:P19338) and ORF57 (uniprotkb:Q2HR75) colocalise
(MI:0403) by ﬂuorescence microscopy (MI:0416)
MINT-7291715: ORF57 (uniprotkb:Q2HR75) and Aly (uniprotkb:Q86V81) colocalise (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Kaposi’s sarcoma-associated herpesvirus (KSHV) ORF57 is an
essential protein conserved amongst all herpesviruses [1–11]. It
is a multi-functional regulator of gene expression assuming many
roles during the course of infection, including transcriptional acti-
vation, enhancing viral splicing and viral mRNA accumulation [12–
14]. Moreover, ORF57 has a pivotal role in the nuclear export of
KSHV lytically-expressed intronless mRNAs [15–18]. This event is
essential for viral replication as intronless transcripts are retained
in the nucleus following transcription due to the splicing-depen-
dent nature of cellular nuclear mRNA export [19–21]. To facilitate
mRNA export, ORF57 shuttles between the nucleus and the cyto-
plasm, binds viral mRNA and recruits the cellular mRNA export
machinery, namely hTREX, via a direct interaction with the export
adapter protein, Aly [22].
Several viral proteins undergo nucleolar trafﬁcking [23],
although for the majority, the functional signiﬁcance of nucleolarchemical Societies. Published by E
lecular and Cellular Biology,
eeds, LS2 9JT, UK. Fax: +44
tehouse).shuttling is unknown. However, nucleolar shuttling of HIV-1 Rev
is essential for viral replication [24] and we have demonstrated
that herpesvirus saimiri (HVS) ORF57 nucleolar shuttling is essen-
tial for viral mRNA export [25]. HVS ORF57 contains two distinct
nuclear localisation signals (NLSs) which are required for nucleolar
trafﬁcking [25]. In contrast, KSHV ORF57 contains three function-
ally independent NLSs [26]. Mutational analysis of these NLSs re-
vealed that in addition to their role in nuclear localisation, they
are also required for efﬁcient export of intronless viral mRNA
[26]. Herein, we assessed if the three independent NLSs have a role
in nucleolar localisation and whether nucleolar trafﬁcking is re-
quired for KSHV ORF57-mediated nuclear export.
2. Materials and methods
2.1. Cell culture, plasmids and transfections
All plasmids have been previously described; pORF57-GFP and
mRNA reporter constructs [22], pORF57-GFP NLS mutants [26],
HVS pORF57-GFP [2]. Primer sequences for the amplication of
ORF47, ORF50 and GAPDH in qRT-PCR assays were previously de-
scribed [22]. HeLa and HEK 293T cells were cultured and transfec-
ted as previous described [22].lsevier B.V. All rights reserved.
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Nucleoli were puriﬁed from 1  107 cells as described else-
where http://www.lamondlab.com/f7nucleolarprotocol.htm.
2.3. Immunoﬂuorescence
Immunoﬂuorescence on adherent cells was carried out as
previously described [27]. Cell were visualised using a LSM 510
META Axioplan 2 microscope (Carl Zeiss Ltd., Germany) using
the LSM Imaging software (Carl Zeiss Ltd., Germany). FRAP
microscopy and data analysis was performed as previously de-
scribed [28].Untreated
TPA (20ng/m
A
B
Untreated TPA (20ng/ml)
E
Fig. 1. KSHV ORF57 localises to the nucleolus during lytic replication. (A) BCBL-1 cells w
performed using an ORF57-speciﬁc antibody (1:100) and detected with an anti-rabbit
(Abcam) detected with an anti-mouse Texas Red conjugate (1:500) (Vector labs) served
reactivated BCBL-1 cells. Indirect immunoﬂuorescence was performed as described abo
nucleoplasm (NP) from untreated or reactivated BCBL-1 cells was analysed by western
determined using the monoclonal nucleolin (1:500) and monoclonal lamin B (1:500) (C
with HRP (1:5000) (Dako). (D) HeLa cells were transiently transfected with KSHV or H
recovery. (E) FRAP of KSHV ORF57-GFP is shown and are representative of three indepe2.4. Immunoprecipitation analysis
Glutathione S-transferase (GST) pull-downs in addition to sub-
sequent protein analysis by SDS–PAGE and western blot performed
as previously described [27,29]. RNA-immunoprecipitations were
carried out as previously described [22,30].
2.5. Real time qRT-PCR
To assess mRNA export efﬁciency, cells were lysed in 200 ll of
PBS 1% Triton-X 100 (v/v) containing 40U of RNAse Out (Invitro-
gen) and nuclear/cytoplasmic fractions isolated and total RNA ex-
tracted using Trizol (Invitrogen) as previously described [22].l)
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as a positive nucleolar marker. (B) Nucleoli were puriﬁed from unreactivated and
ve. (C) Total protein was extracted from puriﬁed nucleoli (NoL) and the remaining
blotting using an ORF57-speciﬁc antibody. The purity of nucleolar fractions was
albiochem) antibodies and detected using a secondary immunoglobulin conjugated
VS ORF57-GFP constructs and FRAP analysis performed to generate a t1/2 value for
ndent repeats.
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Superscript II (Invitrogen) and 20 ng of cDNA used as template in
SensiMixPlus SYBR qRT-PCR reactions (Quantace). qPCR was per-
formed using the Rotor-Gene Q 5plex HRM Platform (Qiagen), with
a standard 3-step melt program (95 C melt for 30 s, 60 C anneal-
ing for 15 s, 72 C extension for 20 s). Following conﬁrmation that
qPCR efﬁciency was comparative between ORF47/ORF50 and the
reference mRNA (GAPDH), quantitative analysis was performed
using DDcT analysis as previously described [31]. Any differencesA
Fig. 2. An ORF57 nucleolar mutant is non-functional but fails to bind intronless viral m
indicated and ORF57 localisation determined via direct visualisation of GFP, nucleoli we
NLSs mutated in each mutant (B) 293T cells were transfected with the vectors indicated a
blot using a probe speciﬁc for ORF47 mRNA. RNA isolated from total cell lysate was inclu
(ii) pgB in the absence or presence of ORF57-GFP or ORF57-GFP mutants. Following UV
antibody and nested RT-PCR performed on the extracted RNA. Total RNA extracted from m
as controls for the RT-PCR (input). (D) GST-pulldown assays were performed to comp
ORF57nls23m-GFP to GST-Aly.observed in mRNA abundance were testing for statistical signiﬁ-
cance by t-test.
3. Results and discussion
3.1. KSHV ORF57 localises to the nucleolus
To determine whether ORF57 trafﬁcks to the nucleolus during a
lytic KSHV replication, indirect immunoﬂuorescence was per-NLS1 NLS2 NLS3
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RNA and interact with Aly. (A) HeLa cells were transfected with the NLS mutant
re stained using a nucleolin-speciﬁc antibody. Schematics to the right highlight the
nd RNA isolated from total, nuclear and cytoplasmic fraction for analysis by northern
ded to control for mRNA stability. (C) 293T cells were transfected with (i) pORF47 or
crosslinking, RNA-immunoprecipitations were performed using an ORF57-speciﬁc
ock transfected and pORF47/ORF57 or pgB/ORF57-transfected 293T cells was used
are the binding of wild type ORF57-GFP, ORF57nls2m-GFP, ORF57nls3m-GFP and
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and nucleolin-speciﬁc antibodies as previously described [25]. A
proportion of ORF57 co-localises with nucleolin in the nucleolus
during lytic replication (Fig. 1A). To conﬁrm the presence of KSHV
ORF57 in the nucleolus, nucleoli were isolated from reactivated
BCBL-1 cells and puriﬁed by high stringency density gradient
fractionation [32]. Puriﬁed nucleoli were then spotted onto poly-L
lysine coated coverslips and indirect immunoﬂuorescence per-
formed as described above. Fig. 1B shows that nucleoli puriﬁed
from reactivated BCBL-1 cells stained positive for ORF57, in con-
trast to untreated BCBL-1 cells. Purity of these fractions was as-
sessed by analysing total protein extracted from puriﬁed
nucleolar and nucleoplasmic fractions. Western blotting was per-
formed using ORF57-, nucleolin- (enriched in nucleolar (NoL) frac-
tion) and lamin-B-speciﬁc (exclusive to nucleoplasmic (NP)
fraction) antibodies. ORF57 was readily detectable in both the
nucleolar and nucleoplasmic fractions isolated from reactivated
cells and absent from all unreactivated fractions. Fractions were47+GFP
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Fig. 2 (contof a high purity as evidenced by the absence of lamin-B and accu-
mulation of nucleolin in the nucleolar fractions (Fig. 1C). Together
these data conﬁrm that ORF57 trafﬁcks to the nucleolus during
KSHV lytic replication.
We next determined whether ORF57 was able to undergo dy-
namic nucleolar trafﬁcking. Fluorescent recovery after photo-
bleaching (FRAP) analysis was performed on HeLa cells transfected
either with KSHV ORF57-GFP or the HVS ORF57 protein, previously
shown to trafﬁc through the nucleolus [25,28]. A single nucleolus
was photo-bleached and the time taken for KSHV ORF57 and
HVS ORF57 to relocalise to this area was determined. FRAP data
analysis was performed as previously described [28,33], and re-
vealed that KSHV ORF57 undergoes dynamic nucleolar trafﬁcking
quicker than HVS ORF57 (Fig. 1D). Why proteins trafﬁc through
the nucleolus at different rates and what determines shuttling
speeds remains unknown, however, it is possible that the triple
NLS of KSHV as opposed to the two NLSs present in HVS ORF57
may contribute to the observed difference in trafﬁcking rates.47+57m
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We next delineated the regions of KSHV ORF57 responsible for
nucleolar localisation. To this end, we utilised a bank of previ-
ously described ORF57 NLS mutants which were mutated in each
of the three NLSs both individually and in each possible combina-
tion [26] (Fig. 2A). HeLa cells were transfected with each of the
ORF57 NLS mutants and indirect immunoﬂuorescence performed
using nucleolin-speciﬁc antibodies to label nucleoli whereas
ORF57 was visualised directly via GFP (Fig. 2A). We observed nu-
clear and cytoplasmic localisation for each of the ORF57 NLS mu-
tants similar to previous ﬁndings [26], however, confocal
microscopy, combined with nucleolin colocalisation data, also re-
vealed an unreported nucleolar localisation state for most mu-
tants (Fig. 2A). Analysis revealed that only two mutants failed
to localise to the nucleolus; ORF57nls123m predominately local-UNTRANSFECTED
UNTREATED
ActD treated
DRB treated
A (i)
Fig. 3. Perturbation of the nucleolus using ActD or DRB severely impairs ORF57-mediate
either vehicle (DMSO), ActD (0.16 mM) or DRB (0.16 lM) for 2 h. Indirect immunoﬂuo
(1:500) (Santa Cruz Biotech) or (ii) a nucleolin-speciﬁc monoclonal antibody (1:500) (Sigm
performed and data for mRNA reporter plus ORF57-transfected cells normalised against c
determine the relative levels of reporter mRNA between samples and a non-paired t-te
levels. Results are taken from three independent experiments.ised to the cytoplasm, whereas ORF57nls23m failed to localise
to the nucleolus but was retained in the nucleus. This suggests
that the presence of either a functional NLS2 or NLS3, in conjunc-
tion with NLS1, is sufﬁcient to localise ORF57 to the nucleolus.
This is in contrast to a report suggesting mutation of the second
NLS alone was sufﬁcient to perturb nucleolar localisation [12].
Interestingly, we observed clear nucleolar localisation of
ORF57nls2m, which lacks a functional NLS2. One explanation for
these differences in data is that Nekorchuk et al. used an
ORF57DNLS mutant deleting a region of ORF57 between amino
acids 118 and 127, whereas this study uses a point mutant that
replaces each basic residue in NLS2 with a neutral or acidic resi-
due. It is possible that deletion of several amino acids from ORF57
results in a more severe phenotype than the NLS2 point mutant,
leading to a nucleolar defect similar to that observed for
ORF57nls23m.ORF57GFP TRANSFECTED
d intronless mRNA export. (A) ORF57-GFP transfected 293T cells were treated with
rescence was performed using (i) a nucleophosmin-speciﬁc monoclonal antibody
a) and then detected with an anti-mouse 633 (1:500) (Invitrogen). (B) qRT-PCR was
ells transfected with reporter in the presence of GFP. A DDcT method was applied to
st performed to determine the signiﬁcance of any observed difference in reporter
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The identiﬁcation of ORF57nls23m as a nucleolar mutant
prompted us to test whether it retained wild type ORF57 function
with respect to intronless mRNA nuclear export [25]. 293T cells
were transfected with a vector expressing the intronless KSHV
ORF47 gene in addition to GFP, ORF57, ORF57nls2m or
ORF57nls23m. Twenty-four hour post-transfection RNA was ex-A (ii) UNTRANSFECTED
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Fig. 3 (conttracted from total, nuclear and cytoplasmic fractions and analysed
by northern blotting. Fig. 2B shows that in the absence of ORF57
the majority of ORF47 mRNA is retained in the nuclear fraction.
However, co-transfection of wild type ORF57 or ORF57nls2m pro-
motes the export of ORF47 mRNA leading to cytoplasmic accumu-
lation of ORF47 mRNA. In contrast, no ORF47 mRNA is detected in
the cytoplasmic fraction of cells co-transfected with ORF57nls23m,
demonstrating that this mutant is unable to promote the nuclearORF57GFP TRANSFECTED
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ORF57 nucleolar trafﬁcking leads to loss of nuclear export function.
However, subsequent analysis of the ORF57nls23 mutant revealed
that it was unable to bind intronless KSHV mRNA (Fig. 2C) and no
longer recruited the export adapter Aly (Fig. 2D), events that are
essential for ORF57-mediated nuclear export [22]. Interestingly,
ORF57nls2m and ORF57nls3m still retained the ability to bind
RNA and interact with Aly (Fig. 2C and D), suggesting that ablation
of both these NLS is required to disrupt the ability of ORF57 to bind
RNA and Aly. These ﬁndings render the northern blot data regard-
ing the role of the nucleolus in KSHV intronless mRNA export
redundant and an alternative functional assay was therefore em-
ployed to assess the role of the nucleolus.
It has previously been reported that treating cells with low con-
centrations of Actinomycin D (ActD) or DRB leads to a rapid redis-
tribution of several nucleolar proteins into the nucleoplasm/
cytoplasm [34]. To test if perturbing the nucleolus in this manner
speciﬁcally affected the efﬁciency of intronless KSHV mRNA ex-
port, 293T cells were transfected with an ORF47 mRNA reporter
construct in the absence or presence of ORF57-GFP. Twenty-four
hour post-transfection cells were either treated with vehicle,
0.16 lM ActD or 0.16 mM DRB for 2 h, ﬁxed and processed by indi-
rect immunoﬂuorescence using nucleophosmin- or nucleolin-spe-
ciﬁc antibodies. Fig. 3A shows that treatment with ActD led to a
rapid loss of both nucleophosmin and nucleolin from the nucleo-
lus, whereas treatment with DRB led to the classical ‘nucleolar
necklace’ phenotype (see arrows Fig. 3Aii) [35]. Analysis of
ORF57 localisation in ActD-treated cells showed that ORF57 is par-
tially redistributed to the nucleoplasm, however, a proportion of
ORF57 was still observed in large nuclear bodies reminiscent of
nucleoli. Similarly, ORF57 was redistributed to the nucleoplasm
in DRB-treated cells and a proportion remained associated with
nucleophosmin and nucleolin in nucleolar necklace structures.
We next tested if the disruption of the nucleolus in ActD- or
DRB-treated cells, had any speciﬁc effect on ORF57-mediated
intronless KSHV mRNA export. To investigate this in a quantitative
manner, qRT-PCR was employed to determine the amount of
intronless ORF47 reporter mRNA resident in the cytoplasm in un-
treated, ActD-treated and DRB-treated cells that co-expressed
ORF57-GFP. Fig. 3B shows a dramatic increase is observed in the
cytoplasmic levels of ORF47 in cells treated with vehicle alone
(25-fold). Strikingly, treatment with either ActD or DRB signiﬁ-
cantly reduced the amount of ORF47 in the cytoplasmic fraction
(8-fold), suggesting the relocalisation of cellular nucleolar pro-
teins following treatment with ActD or the disruption to nucleolar
structure by DRB both negatively effected the ability of ORF57 to
mediate intronless KSHV mRNA export.
While ActD and DRB disrupt the nucleolus at low concentra-
tions, higher doses inhibit transcription. To ensure that the ob-
served reduction for cytoplasmic intronless KSHV mRNA was not
due to an ActD- or DRB-mediated down-regulation of transcription
we also determined the levels of spliced ORF50 mRNA, which is ex-
ported in an ORF57-independent manner [22], in either the pres-
ence of ActD or DRB. We did observe a general decrease in
ORF50 mRNA levels in cells co-transfected with ORF57 compared
to GFP-control (Fig. 3B), similar to recent ﬁndings reported for
the EBV ORF57 homologue showing that it negatively regulates
EBV gene expression [36], however no signiﬁcant difference in
ORF50 mRNA levels was observed between untreated cells and
cells treated with either ActD or DRB. Moreover, we were unable
to detect any signiﬁcant difference (pP 0.05 for all samples) in
ORF57 mRNA levels following treatment with ActD or DRB (Sup-
plementary Fig. 1). It should be noted, however, that if ORF57 re-
cruits the hTREX complex in a co-transcriptional manner, as
current models would suggest [37], then it is possible that low con-
centration of ActD or DRB could effect transcription sufﬁciently toimpair ORF57 nuclear export function at the level of co-transcrip-
tional recruitment.
Results herein offer the ﬁrst detailed analysis of KSHV ORF57
nucleolar shuttling. We demonstrate that ORF57 undergoes dy-
namic nucleolar trafﬁcking in lytic KSHV cells. Analysis of
ORF57-GFP mutants revealed that either NLS2 or NLS3 in combina-
tion with NLS1 are able to function as NoLSs in the context of the
full length ORF57 protein. Moreover, we have demonstrated that
ORF57nls23m, which is unable to trafﬁck to the nucleolus and does
not promote the export of intronless viral mRNA also fails to inter-
act with either the intronless mRNA or Aly, invalidating its use in
functional studies. However, by manipulating the nucleolus using
cytotoxic drugs we report an interesting and novel ﬁnding. The
redistribution of cellular nucleolar proteins, which leads to a loss
of nucleolar structure, led to a marked decrease in the efﬁciency
by which ORF57 exports intronless KSHV mRNA. These data sug-
gest that intact nucleoli are required for efﬁcient ORF57-mediated
nuclear export. The precise role of the nucleolus in viral mRNA ex-
port is yet to be determined, and presently we are investigating its
possible effects on viral mRNA/protein processing and viral ribonu-
cleoprotein particle assembly.
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